Virios Therapeutics, Inc.
VIRI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,744,616 | -$3,807,353 | -$10,924,952 | -$12,346,280 |
| Dep. & Amort. | $2,063 | $0 | $52,373 | $70,609 |
| Deferred Tax | -$1,436 | $149 | $190,542 | -$503 |
| Stock-Based Comp. | $48,281 | $65,027 | $84,474 | $475,585 |
| Change in WC | $0 | $0 | $0 | $210 |
| Other Non-Cash | $12,422,916 | -$283,941 | $5,915,009 | $3,012,792 |
| Operating Cash Flow | -$3,272,792 | -$4,026,118 | -$4,682,554 | -$8,787,587 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $3,761,936 |
| Investing Cash Flow | $0 | $0 | $0 | $3,761,936 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | -$120,133 | $4,372,378 | $1,379,561 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | -$1,256,662 | -$514,105 |
| Other Fin. Act. | $0 | -$120,133 | $8,629,040 | $17,214,804 |
| Financing Cash Flow | $0 | -$120,133 | $7,372,378 | $16,700,699 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,276,099 | -$4,136,195 | $2,691,055 | $14,844,929 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,402,809 | $17,539,004 | $14,847,949 | $3,020 |
| End Cash | $10,126,710 | $13,402,809 | $17,539,004 | $14,847,949 |
| Free Cash Flow | -$3,272,792 | -$4,026,118 | -$4,682,554 | -$8,787,587 |